European Archives - Page 313 of 1006 - European Medical Journal

Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis

This case report aims to unveil the possible differentials and processes involved in the diagnosis of marantic endocarditis…

Using Behavioural Science to Help Understand Vaccine Hesitancy

This article is based on a Learning Lounge educational session that took place on 22nd October 2022, as part of Infectious Diseases Society of America (IDSA) IDWeek™ 2022 held in Washington, D.C., USA.

EMJ Microbiology and Infectious Diseases 4 [Supplement 1] 2023

This review article covers the learning lounge educational session that took place on 22nd of October 2022, as part of IDWeek 2022, held in Washington D.C., USA.

Mitral Annular Calcification Causing Retinal
Artery Occlusion

Caseous mitral annular calcification (CMAC), sometimes called liquefaction necrosis of mitral annular calcification (MAC), is a rare variant of MAC, a chronic degenerative process that progresses with age.

The brains behind neurological breakthroughs

The recent approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?

Eli Lilly improves cold chain capacity

Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.

Pharma in Poland

Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.

A Voice in the Wilderness: Treating Headache and Migraine

The correct classification and differentiation of headaches and migraines are key in their management.

Epidemiological Features of SARS-CoV-2 in Northern Greece

The COVID-19 pandemic has been a huge challenge for the Greek National Health System. Real-time reverse transcription PCR (rtRT-PCR) remains the reference method for early diagnosis, contact tracing, and containment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Reflections and predictions for 2023

Explore the key trends and themes industry experts predict will be in store for pharma over the next 12 months.